CancerIQ logo

CancerIQ

We connect a broader population of patients and providers to innovations in prevention, early detection, and treatment.

39 employees · est. 2013 · Chicago, United States

VS
Invitae logo

Invitae

As a Labcorp company, we’re bringing comprehensive genetic information into mainstream medicine to improve healthcare.

679 employees · est. 2010 · San Francisco, United States

Invitae is the older company (2013 vs 2010); Invitae is the larger of the two.

Side-by-Side Comparison

CancerIQ Invitae
Founded
2013 2010 older
Headquarters
Chicago, United States San Francisco, United States
Employees
39 679 larger
Industry
Health Care, Information Technology Biotechnology, Health Care
Funding Stage
Convertible Note Acquired
Total Funding
$20.00M $2.56B
Funding Rounds
7 16
Services
Not tracked yet genetic testing, genetic counseling, test catalog, personal health insights
Target Customers
Not tracked yet patients, healthcare providers, biopharma partners, advocacy groups
Taxonomy
Precision Medicine, Genetic Information, Cancer Prevention, Healthcare IT, Oncology, Big Data Analytics, Genetic Testing, Risk Prediction, Patient Engagement Genetic Testing, Medical Genetics, Hereditary Disorders, Genomics, Genetic Diagnostics, Genetic Information Systems, Genome Management, Digital Health Technology, Artificial Intelligence In Healthcare, Machine Learning In Genetics, Oncology Diagnostics, Rare Genetic Disease Solutions, Pediatric Genetics
Website
canceriq.com invitae.com
CancerIQ logo

About CancerIQ

CancerIQ is a health tech startup founded in 2013 in the United States. The company's motto is "We connect a broader population of patients and providers to innovations in prevention, early detection, and treatment." CancerIQ assists healthcare providers in utilizing genetic information to predict,...

Invitae logo

About Invitae

Invitae, now part of LabCorp, is a prominent player in the Biotechnology and Health Care industries, founded in 2010. The company is headquartered in the United States and operates with a mission to integrate comprehensive genetic information into mainstream medicine, thus enhancing healthcare outco...

We will tell you when either one moves

BounceWatch watches CancerIQ and Invitae for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at CancerIQ and Invitae — by email.

Frequently Asked Questions

CancerIQ — We connect a broader population of patients and providers to innovations in prevention, early detection, and treatment.. Invitae — As a Labcorp company, we’re bringing comprehensive genetic information into mainstream medicine to improve healthcare.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
CancerIQ has raised $20.00M while Invitae has raised $2.56B.
CancerIQ and Invitae operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare CancerIQ with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at CancerIQ on 12 Sep 2024, and Invitae on 10 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy